Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

NCT02926651 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Anemia
Arthritis
Total Knee Arthroplasty
Total Hip Arthroplasty

Interventions

DRUG: Conventional Oral TXA (Tranexamic Acid)
DRUG: Multi-Dose Oral TXA (Tranexamic Acid)

Sponsor

Rush University Medical Center